TRAVERE THERAPEUTICS, INC.
TVTX · NASDAQ
Travere Therapeutics is a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, the company knows the need for treatment options is urgent - that is why its global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, Travere continuously seeks to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope - today and tomorrow.
Market Data
Price
$53.44
-2.54 (-4.54%)
Market Cap$5.04B
P/E Ratio—
EPS$—
52W High$68.73
52W Low$22.59
Beta1.07
Data from Finnhub · Updated Oct 8, 2026